Literature DB >> 2591056

Bone mass in hirsute women with androgen excess.

J E Dixon1, A Rodin, B Murby, M G Chapman, I Fogelman.   

Abstract

The spinal and femoral bone mass of 32 hirsute women with oligomenorrhoea and androgen excess was measured using dual photon absorptiometry and compared with the bone mass of 32 control women with regular menstrual cycles. Despite significantly lower oestradiol levels in the hirsute population there was no significant difference in the bone mass. Furthermore there was no significant difference in bone mass in five hirsute women with undetectable levels of oestradiol. It is concluded that androgen excess can maintain normal bone mass in the face of low or undetectable oestradiol levels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2591056     DOI: 10.1111/j.1365-2265.1989.tb02235.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Impact of bone mineral measurements on osteoporosis.

Authors:  I Fogelman; A Rodin; G Blake
Journal:  Eur J Nucl Med       Date:  1990

2.  Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women.

Authors:  C Slemenda; C Longcope; M Peacock; S Hui; C C Johnston
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

3.  Intermittent Etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist.

Authors:  N Zamberlan; R Castello; D Gatti; M Rossini; V Braga; E Fracassi; S Adami
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 4.  Body fat assessment in women. Special considerations.

Authors:  J A Vogel; K E Friedl
Journal:  Sports Med       Date:  1992-04       Impact factor: 11.136

5.  Casodex (a nonsteroidal antiandrogen) reduces cancellous, endosteal, and periosteal bone formation in estrogen-replete female rats.

Authors:  C Lea; N Kendall; A M Flanagan
Journal:  Calcif Tissue Int       Date:  1996-04       Impact factor: 4.333

6.  GH-binding protein is related to bone mineral density in non-obese androgenized women.

Authors:  M Legan; J Osredkar; S Fisker; A Kocijancic
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

Review 7.  Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy.

Authors:  Jia-Feng Chen; Pei-Wen Lin; Yi-Ru Tsai; Yi-Chien Yang; Hong-Yo Kang
Journal:  Cells       Date:  2019-10-25       Impact factor: 6.600

Review 8.  The impact of sex steroids on osteonecrosis of the jaw.

Authors:  Ranhee Kim; Sung Woo Kim; Hoon Kim; Seung-Yup Ku
Journal:  Osteoporos Sarcopenia       Date:  2022-06-17

9.  Bone mineral density in women with polycystic ovary syndrome.

Authors:  K Katulski; S Slawek; A Czyzyk; A Podfigurna-Stopa; K Paczkowska; N Ignaszak; N Podkowa; B Meczekalski
Journal:  J Endocrinol Invest       Date:  2014-09-23       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.